Literature DB >> 30772453

Glyco-recoded Escherichia coli: Recombineering-based genome editing of native polysaccharide biosynthesis gene clusters.

Laura E Yates1, Aravind Natarajan2, Mingji Li1, Margaret E Hale1, Dominic C Mills1, Matthew P DeLisa3.   

Abstract

Recombineering-based redesign of bacterial genomes by adding, removing or editing large segments of genomic DNA is emerging as a powerful technique for expanding the range of functions that an organism can perform. Here, we describe a glyco-recoding strategy whereby major non-essential polysaccharide gene clusters in K-12 Escherichia coli are replaced with orthogonal glycosylation components for both biosynthesis of heterologous glycan structures and site-specific glycan conjugation to target proteins. Specifically, the native enterobacterial common antigen (ECA) and O-polysaccharide (O-PS) antigen loci were systematically replaced with ∼9-10 kbp of synthetic DNA encoding Campylobacter jejuni enzymes required for asparagine-linked (N-linked) protein glycosylation. Compared to E. coli cells carrying the same glycosylation machinery on extrachromosomal plasmids, glyco-recoded strains attached glycans to acceptor protein targets with equal or greater efficiency while exhibiting markedly better growth phenotypes and higher glycoprotein titers. Overall, our results define a convenient and reliable framework for bacterial glycome editing that provides a more stable route for chemical diversification of proteins in vivo and effectively expands the bacterial glycoengineering toolkit.
Copyright © 2019 International Metabolic Engineering Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30772453     DOI: 10.1016/j.ymben.2019.02.002

Source DB:  PubMed          Journal:  Metab Eng        ISSN: 1096-7176            Impact factor:   9.783


  10 in total

Review 1.  Glycoengineering bioconjugate vaccines, therapeutics, and diagnostics in E. coli.

Authors:  Christian M Harding; Mario F Feldman
Journal:  Glycobiology       Date:  2019-07-01       Impact factor: 4.313

2.  Production of Vaccines Using Biological Conjugation.

Authors:  Emily J Kay; Vanessa S Terra
Journal:  Methods Mol Biol       Date:  2022

3.  Recombineering and MAGE.

Authors:  Timothy M Wannier; Peter N Ciaccia; Andrew D Ellington; Gabriel T Filsinger; Farren J Isaacs; Kamyab Javanmardi; Michaela A Jones; Aditya M Kunjapur; Akos Nyerges; Csaba Pal; Max G Schubert; George M Church
Journal:  Nat Rev Methods Primers       Date:  2021-01-14

4.  Engineering a suite of E. coli strains for enhanced expression of bacterial polysaccharides and glycoconjugate vaccines.

Authors:  Emily J Kay; Marta Mauri; Sam J Willcocks; Timothy A Scott; Jon Cuccui; Brendan W Wren
Journal:  Microb Cell Fact       Date:  2022-04-21       Impact factor: 6.352

Review 5.  Recent advances in the production of recombinant glycoconjugate vaccines.

Authors:  Emily Kay; Jon Cuccui; Brendan W Wren
Journal:  NPJ Vaccines       Date:  2019-05-01       Impact factor: 7.344

6.  An Engineered Pathway for Production of Terminally Sialylated N-glycoproteins in the Periplasm of Escherichia coli.

Authors:  Jing Zhu; Yao Ruan; Xin Fu; Lichao Zhang; Gaoshun Ge; J Gerard Wall; Teng Zou; Yang Zheng; Ning Ding; Xuejun Hu
Journal:  Front Bioeng Biotechnol       Date:  2020-04-15

7.  PglB function and glycosylation efficiency is temperature dependent when the pgl locus is integrated in the Escherichia coli chromosome.

Authors:  Vanessa S Terra; Marta Mauri; Thippeswamy H Sannasiddappa; Alexander A Smith; Mark P Stevens; Andrew J Grant; Brendan W Wren; Jon Cuccui
Journal:  Microb Cell Fact       Date:  2022-01-05       Impact factor: 5.328

8.  Genetic and process engineering strategies for enhanced recombinant N-glycoprotein production in bacteria.

Authors:  Fenryco Pratama; Dennis Linton; Neil Dixon
Journal:  Microb Cell Fact       Date:  2021-10-14       Impact factor: 5.328

Review 9.  Strategies for efficient production of recombinant proteins in Escherichia coli: alleviating the host burden and enhancing protein activity.

Authors:  Zi-Xu Zhang; Fang-Tong Nong; Yu-Zhou Wang; Chun-Xiao Yan; Yang Gu; Ping Song; Xiao-Man Sun
Journal:  Microb Cell Fact       Date:  2022-09-15       Impact factor: 6.352

10.  Multivalent poultry vaccine development using Protein Glycan Coupling Technology.

Authors:  Marta Mauri; Thippeswamy H Sannasiddappa; Prerna Vohra; Mark P Stevens; Andrew J Grant; Jon Cuccui; Brendan W Wren; Ricardo Corona-Torres; Alexander A Smith; Cosmin Chintoan-Uta; Abi Bremner; Vanessa S Terra; Sherif Abouelhadid
Journal:  Microb Cell Fact       Date:  2021-10-02       Impact factor: 5.328

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.